Boardroom Alpha
Start trial
S-1/A primary document
ESLA · Amended Registration Statement (Form S-1/A) · Filed January 16, 2026

Estrella Immunopharma Inc — S-1/A exhibit

ea026916102ex-fee_estrella.htm
Estrella Immunopharma Inc on Boardroom Alpha
Filing Fee Exhibit

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Estrella Immunopharma, Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common stock, $0.0001 par value per share   (1)   457(a)   6,694,935   $ 1.0225   $ 6,845,571.04   0.0001381   $ 945.37
Fees Previously Paid   Equity   Common stock, $0.0001 par value per share   (2)   457(a)   2,541,206   $ 1.6750   $ 4,256,520.05   0.0001381   $ 587.83
                                           
Total Offering Amounts:   $ 11,102,091.09         1,533.20
Total Fees Previously Paid:               587.83
Total Fee Offsets:               0.00
Net Fee Due:             $ 945.37

__________________________________________
Offering Note(s)

(1) This Amendment No. 1 registers an additional 6,694,935 shares of common stock for resale by the selling stockholders. The proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(a) and 457(c) under the Securities Act and is based on the average of the high and low prices of the registrant's common stock as reported on January 15, 2026.
(2) The registrant previously paid a filing fee of $ 587.83 in connection with the initial filing of this Registration Statement on December 22, 2025. The proposed maximum offering price per share was estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(a) and 457(c) under the Securities Act and was based on the average of the high and low prices of the registrant's common stock as reported on December 19, 2025. The filing fee previously paid is credited against the total filing fee due for the Registration Statement in accordance with Rule 457(b) under the Securities Act.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer